Not applicableStudy completedNCT02751710
What this trial is testing
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Who this might be right for
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)Stage IIb Breast Cancer (T3N0)
Ontario Clinical Oncology Group (OCOG) 369